Kyowa Kirinincis The North American Subsidiary Of Kyowa Kirin Co Ltd A Global Specialty Pharmaceutical Company Based In Japanthe U Sdivision Focuses On Biotechnology To Develop And Commercialize Innovative Therapies For Rare And Serious Diseasessince Its Establishmentthe Company Has Experienced Significant Growthparticularly After Receiving Fda Approvals For First In Class Medicineswith Over 600 Employeeskyowa Kirin Operates Offices In Princetonnjtorontocanadaand A Research Facility In La Jollaca The Company Specializes In Biopharmaceutical Research And Developmentmanufacturingand Commercialization Of Specialty Drugsits Key Focus Areas Include Nephrologyoncologyand Immunologyproviding Treatments For Chronic Kidney Diseaserare Cancersand Autoimmune Disorderskyowa Kirin Serves Healthcare Providershospitalsand Patientscollaborating With Clinical Researchers And Biotech Partners To Enhance Drug Developmentthe Company Is Committed To Teamworkintegrityand Patient Centric Innovationreflecting Its Mission To Leverage Biotechnology For Improved Patient Outcomes
